Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arteris (AIP) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Arteris (AIP) over the last 3 years, with Q4 2025 value amounting to $19.1 million.

  • Arteris' Accumulated Expenses rose 2009.56% to $19.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $19.1 million, marking a year-over-year increase of 2009.56%. This contributed to the annual value of $19.1 million for FY2025, which is 2009.56% up from last year.
  • Arteris' Accumulated Expenses amounted to $19.1 million in Q4 2025, which was up 2009.56% from $17.2 million recorded in Q3 2025.
  • Arteris' Accumulated Expenses' 5-year high stood at $19.1 million during Q4 2025, with a 5-year trough of $10.0 million in Q1 2023.
  • In the last 3 years, Arteris' Accumulated Expenses had a median value of $12.8 million in 2024 and averaged $13.6 million.
  • Over the last 5 years, Arteris' Accumulated Expenses had its largest YoY gain of 3438.42% in 2024, and its largest YoY loss of 820.32% in 2024.
  • Quarter analysis of 3 years shows Arteris' Accumulated Expenses stood at $11.8 million in 2023, then soared by 34.38% to $15.9 million in 2024, then increased by 20.1% to $19.1 million in 2025.
  • Its Accumulated Expenses stands at $19.1 million for Q4 2025, versus $17.2 million for Q3 2025 and $15.3 million for Q2 2025.